PNC Financial Services Group
CRBP icon

PNC Financial Services Group’s Corbus Pharmaceuticals CRBP Stock Holding History

PNC Financial Services Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4
Closed -$1K – 3938
2020
Q2 		$1K Buy
+4
New +$808 ﹤0.01% 3838
2017
Q3 		– Sell
-17
Closed -$3K – 4150
2017
Q2 		$3K Hold
17
– – ﹤0.01% 3912
2017
Q1 		$4K Buy
+17
New +$4.17K ﹤0.01% 3787

Other funds holding CRBP

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

PNC Financial Services Group's CRBP Position: Q3 2020 in Review

PNC Financial Services Group sold out of Corbus Pharmaceuticals (CRBP) in Q3 2020, closing a stake of 4 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in CRBP in Q1 2017 and held it in 3 quarters. The position peaked at $4K in Q1 2017. 122 funds tracked by Wall St. Rank hold CRBP as of Q3 2020.

  • PNC Financial Services Group reported no remaining Corbus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 4 Corbus Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • PNC Financial Services Group first reported a position in Corbus Pharmaceuticals in Q1 2017 and held it in 3 quarters.
  • PNC Financial Services Group's Corbus Pharmaceuticals position peaked at $4K in Q1 2017.
  • 122 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2020.

Based on PNC Financial Services Group's 13F filing for Q3 2020, filed 6 Nov 2020.